Hologic/HOLX

$74.92

-0.25%
-
1D1W1MYTD1YMAX

About Hologic

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.

Ticker

HOLX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Stephen Macmillan

Employees

6,990

Headquarters

Marlborough, United States

Hologic Metrics

BasicAdvanced
$18.2B
Market cap
36.86
P/E ratio
$2.10
EPS
1.01
Beta
-
Dividend rate
$18.2B
1.00748
$87.88
$64.02
1.77M
3.887
3.182
54.523
55.396
27.639
5.8%
10.57%
6.48%
36.863
4.585
3.908
35.328
21.196
-11.12%
-46.35%
2.19%
-24.24%

What the Analysts think about Hologic

Analyst Ratings

Majority rating from 18 analysts.
Buy

Price Targets

Average projection from 14 analysts.
14.88% upside
High $95.00
Low $78.00
$74.92
Current price
$86.07
Average price target

Hologic Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.33% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.01B
7.17%
Net income
$246.5M
172.08%
Profit margin
24.33%
153.97%

Hologic Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.03%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.06
$0.93
$0.89
$0.98
-
Expected
$0.88
$0.89
$0.84
$0.95
$0.98
Surprise
20.24%
4.43%
5.86%
3.03%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Hologic stock?

Hologic (HOLX) has a market cap of $18.2B as of April 17, 2024.

What is the P/E ratio for Hologic stock?

The price to earnings (P/E) ratio for Hologic (HOLX) stock is 36.86 as of April 17, 2024.

Does Hologic stock pay dividends?

No, Hologic (HOLX) stock does not pay dividends to its shareholders as of April 17, 2024.

When is the next Hologic dividend payment date?

Hologic (HOLX) stock does not pay dividends to its shareholders.

What is the beta indicator for Hologic?

Hologic (HOLX) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Hologic stock price target?

The target price for Hologic (HOLX) stock is $86.07, which is 14.88% above the current price of $74.92. This is an average based on projections from 14 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Hologic stock

Buy or sell Hologic stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing